Avricore Health Inc.
AVCR.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 876.20K | 763.80K | 833.90K | 995.50K | 710.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 876.20K | 763.80K | 833.90K | 995.50K | 710.80K |
| Cost of Revenue | 557.50K | 492.90K | 474.30K | 626.90K | 515.70K |
| Gross Profit | 318.80K | 271.00K | 359.60K | 368.60K | 195.20K |
| SG&A Expenses | 432.30K | 218.50K | 226.70K | 311.70K | 395.00K |
| Depreciation & Amortization | 500.00 | 500.00 | 500.00 | 400.00 | 500.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 990.30K | 711.90K | 701.60K | 939.00K | 911.20K |
| Operating Income | -114.10K | 51.90K | 132.30K | 56.50K | -200.40K |
| Income Before Tax | -131.30K | 39.50K | 125.00K | 43.80K | -212.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -131.30K | 39.50K | 125.00K | 43.80K | -212.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -131.30K | 39.50K | 125.00K | 43.80K | -212.50K |
| EBIT | -114.10K | 51.90K | 132.30K | 56.50K | -200.40K |
| EBITDA | -31.30K | 131.40K | 211.70K | 151.30K | -110.60K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 100.40M | 99.87M | 99.74M | 99.67M | 99.64M |
| Average Diluted Shares Outstanding | 100.40M | 105.61M | 99.74M | 99.67M | 99.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |